Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia

Clinical trial NCT02864654 · UNKNOWN

Trial details

NCT number: NCT02864654
Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia Arteriosclerosis Obliterans Peripheral Arterial Disease Thromboangiitis Obliterans Diabetic Angiopathies

Start date: 2016-07-01
Primary completion: 2017-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.